DNLI
Price:
$25.25
Market Cap:
$3.61B
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatment of Parkinson's disease. The company also develops DNL310 that is in Phase I/II clinical trials for the treatment of hunter syndrome; DNL343, which is in phase 1 clinical trial the treatment of amyotrophic lateral sclerosis (ALS); AR443820/DNL788 completed a phase I clinical trial for the treatment of ALS, multiple sclerosis (MS), and Alzheimer's d...[Read more]
Industry
Biotechnology
IPO Date
2017-12-08
Stock Exchange
NASDAQ
Ticker
DNLI
According to Denali Therapeutics Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Denali Therapeutics Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), DNLI's Dividend Yield was at its highest in in the March 2016 quarter at 0%. The Dividend Yield was at its lowest in in the March 2016 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Denali Therapeutics Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2023 | 0% | 0% |
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
2019 | 0% | 0% |
2018 | 0% | 0% |
2017 | 0% | 0% |
2016 | 0% | 0% |
The current Dividend Yield of Denali Therapeutics Inc. (DNLI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Denali Therapeutics Inc.’s Dividend Yield is less than Homology Medicines, Inc. (0%), less than Stoke Therapeutics, Inc. (0%), less than Atreca, Inc. (0%), less than Black Diamond Therapeutics, Inc. (0%), less than 4D Molecular Therapeutics, Inc. (0%), less than Ascendis Pharma A/S (0%), less than Apellis Pharmaceuticals, Inc. (0%), less than BeiGene, Ltd. (0%), less than Akero Therapeutics, Inc. (0%), less than Blueprint Medicines Corporation (0%), less than Legend Biotech Corporation (0%), less than Vaxcyte, Inc. (0%), less than Travere Therapeutics, Inc. (0%), less than Cerevel Therapeutics Holdings, Inc. (0%), less than Avidity Biosciences, Inc. (0%), less than Revolution Medicines, Inc. (0%), less than Day One Biopharmaceuticals, Inc. (0%), less than SpringWorks Therapeutics, Inc. (0%), less than Monte Rosa Therapeutics, Inc. (0%), less than Design Therapeutics, Inc. (0%), less than Werewolf Therapeutics, Inc. (0%), less than Ikena Oncology, Inc. (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $3.02M | |
0% | $773.92M | |
0% | $3.57M | |
0% | $305.13M | |
0% | $783.18M | |
0% | $6.83B | |
0% | $5.00B | |
0% | $21.01B | |
0% | $1.83B | |
0% | $5.47B | |
0% | $9.90B | |
0% | $12.45B | |
0% | $839.88M | |
0% | $8.19B | |
0% | $4.74B | |
0% | $6.99B | |
0% | $1.25B | |
0% | $2.88B | |
0% | $349.21M | |
0% | $264.42M | |
0% | $88.28M | |
0% | $81.56M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Denali Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Denali Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Denali Therapeutics Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Denali Therapeutics Inc. (DNLI)?
What is the highest Dividend Yield for Denali Therapeutics Inc. (DNLI)?
What is the 3-year average Dividend Yield for Denali Therapeutics Inc. (DNLI)?
What is the 5-year average Dividend Yield for Denali Therapeutics Inc. (DNLI)?
How does the current Dividend Yield for Denali Therapeutics Inc. (DNLI) compare to its historical average?